Consolidated health systems will enable data-driven research as care options—leveraging sophisticated patient data pools, analytics and population health in combination with advanced research for cutting edge new treatments.
We have written about the ongoing health provider consolidation occurring in the United States. As the markets and landscape continue to change consolidation, scale and efficiencies are powerful elements factored into health system executive leadership decision making. This not only impacts (for good or for bad) patients but also clinical investigations as these health providers run considerable numbers of clinical trials.
Modern Healthcare reports that Atrium Health, Wake Forest Baptist Health and Wake Forest University have signed an MOU to merge. All are non-profit based organizations committed to healthcare in North Carolina. Now that the trio enter into exclusive negotiations the inking of the deal should take about one year. Combining Charlotte-based Atrium (42 hospitals) and Winston-Salem-based Wake Forest Baptist’s (7 hospitals) the deal would also expand Wake Forest University’s “footprint” with a second campus in Charlotte.
This consolidated system would have access to 6.8 million residents’ data which will be leveraged for advanced care coordination and importantly for purposes of TrialSite News readers, a research population health center. Healthcare executives are operating with a bolder, data-driven vision moving forward. By integrating research with population health, the new combined system could link “breakthrough science directly with patients in a way that significantly enhances their cognitive and physical functioning—and allows them to live independently for longer” reported Eugene Woods, president and CEO of Atrium Health. Integrated provider data can lead to coordinated clinical research and breakthrough clinical research as care options.